MedPath

Comparison of standard anti-Helicobacter pylori eradication regimen with and without N Acetylcysteine ??in patients with dyspepsia

Phase 2
Conditions
Dyspepsia.
Helicobacter pylori [H.pylori] as the cause of diseases classified
Registration Number
IRCT201201078634N1
Lead Sponsor
Vice chancellor for research, Isfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Inclusion criteria included: All patients with gastrointestinal symptoms and dyspepsia which refer to the Gastroenterology Clinics of Al-Zahra hospital, Noor, Poursina Hakim Research Center and Ardakan hospital for endoscopy by a gastroenterologist recruited with full consent if Helicobacter pylori tests were positive (confirmed by histology, Rapid urease test or stool antigen test). Exclusion criteria included: Patients previously received eradication of Helicobacter pylori treatment? Presence of underlying disease such as cirrhosis? Renal failure? Severe cardiac disease? malignancy outside of the GI? Age less than 17 and more than 80? Simultaneous use of NSAIDs? Concomitant use of steroids? Recent gastrointestinal bleeding? pregnancy or lactation.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Helicobacter pylori eradication. Timepoint: Prior to and one month after intervention. Method of measurement: Stool antigen.
Secondary Outcome Measures
NameTimeMethod
Drug side effects. Timepoint: During and after drug consumption. Method of measurement: Visiting and call-chek list.;Drug tolerance. Timepoint: During drug consumption. Method of measurement: Visiting and call.
© Copyright 2025. All Rights Reserved by MedPath